Search

everythinglearnresearchcommunity

for

Search:↓

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

17β-estradiol may help hair growth by increasing cannabinoid receptor type 1.

CAP1/Prss8 does not activate PAR2 or inhibit PN-1.

ERK activation spreads between cells in mouse skin, linked to cell division and influenced by TPA and EGF receptors.

Meis2 is essential for touch sensation and nerve function in mice.

Phospholipids help plant proteins move by regulating receptor interactions.

P2X₃-IR fibers are widespread in rat skin and likely help detect pain.

TCDD reduces EGF receptors in the liver, affecting growth and development.

XEDAR triggers a specific signaling pathway in cells.

VEGF stimulates hair cell growth and increases growth receptor levels through a specific signaling pathway.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

EGF–FGF2 helps mouse stem cells grow and become more like nerve cells.

Phaeodactylum tricornutum extract helps hair follicle cells grow by activating the ERK1/2 pathway.

The PP2A-B55α protein is essential for brain and skin development in embryos.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Human skin cells produce proenkephalin, which changes with environmental factors and skin diseases.

Epiprofin suppresses parathyroid hormone gene activity, helping regulate calcium levels and could be a treatment target for hyperparathyroidism.

Pyrene excimer nucleic acid probes are promising for detecting biomolecules accurately with potential for biological research and drug screening.

Blocking adenosine A2B receptor may prevent or treat hearing loss.

DORN1 receptor affects eATP-induced stomatal changes but not eADP in Arabidopsis thaliana.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Erythematous papulopustular eruptions in cancer patients using EGFR inhibitors show specific skin changes that vary with severity and treatment type.

Dermal EZH2 controls skin cell development and hair growth in mice.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.